Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2, randomized, double-blind, double-dummy, multicenter, prospective study to
assess the efficacy, safety, and pharmacokinetics of two dose regimens of TP-434 compared
with ertapenem in the treatment of adult community-acquired complicated intra-abdominal
infections (cIAIs).